NORYVA
Ipamorelin
Designed to touch one thing where its elders touched several.
10 mg
Ipamorelin is an entirely artificial molecule, designed to aim at a single target where older molecules in its family hit several at once. It is this precision that makes it a subject of study.
- A targeted action, not a general one.
- The growth hormone route, taken by a single way in.
- Old human data, and a development that stopped.
What is being looked at?
- Hunger signal
- Precision of action
- The body’s own signals
The essentials
- Format
- 10 mg
- Storage · Batch number · Manufactured · Expiry · Batch purity
- On the batch certificate
- Evidence level
- Early human data
- Use
- For research and laboratory use only.
The question you are asking yourself
Why did its development stop?
It stopped, and we will not tell that story on its behalf: the human data that exist are old, and no file was carried to completion. It is the most important limit on this page, which is why it is written here and not at the bottom.
Why this reference?
Older molecules in the same family touched several targets at once. This one was drawn to aim at a single one. That precision is what is studied — and it is also all the available work allows one to say: clinical development stopped, and the human data that exist are old.
What you should know
Scientific detail
What it is
Ipamorelin is a synthetic pentapeptide, an agonist of the ghrelin receptor (GHS-R1a). It is an entirely artificial molecule: it does not occur in the body.
Why it is studied
The ghrelin receptor takes part in regulating growth-hormone release. Ipamorelin is used to study that pathway with a selectivity older molecules did not have.
Described mechanism
Proposed mechanism: selective agonism of the GHS-R1a receptor. The selectivity described in the literature concerns experimental models, not a practice.
What the research has studied
- Ghrelin receptor
- Hunger signal
- Selectivity
Human data
Older clinical studies exist, run for specific indications over short durations. They do not transfer to another setting.
Preclinical data
Animal data on selectivity and growth-hormone release.
What the data does not say
Clinical development discontinued; no marketing authorisation. Old human data are not current data.
Regulatory status
For laboratory research purposes only. Not for human consumption or therapeutic use.
This reference holds no marketing authorisation as a medicinal product.
Customer reviews
Frequently asked questions
Can I order Ipamorelin today?
No. This reference is not offered for sale: its commercial framework is not settled. No purchase button is shown until it is.
Does Ipamorelin hold a marketing authorisation?
No. This reference holds no marketing authorisation as a medicinal product and is approved by no authority for human use. A publication or a clinical trial never amounts to approval.
What analyses are available?
The certificate of analysis is supplied with the batch delivered. No batch number or purity figure is published until the real certificate has been entered: we do not display illustrative values.
How is this reference stored?
The storage requirement is not yet on file: the supplier data sheet has not reached us. We would rather say so than assume.
Is it compatible with the NORYVA injector pen?
Compatibility is not confirmed for this reference. Until the manufacturer confirms it, we do not claim it.
What does the available data actually show?
Clinical development discontinued; no marketing authorisation. Old human data are not current data.
Work out a volume
The vial amount is prefilled from this page. The solvent volume and the amount aimed for are yours to enter: NORYVA proposes neither.